CELL-BASED THERAPY

“Recent advances in cellular and molecular biology have increased our understanding of the pathophysiological mechanisms underlying retinal degenerative diseases and consequently enabled expansion of translational research. Therefore, it seemed appropriate to develop a text exploring applications of stem cell therapy to the treatment of these major causes of blindness,” said Dr Casaroli-Marano, professor and researcher, Department of Surgery and Surgical Specializations (School of Medicine), University of Barcelona, Spain.
Dr Zarbin noted that with the entry of cell-based therapy for retinal degenerative diseases into human studies and as the numbers of those trials are growing, various groups of individuals will have an interest in learning more about this topic.
“This book provides a comprehensive, scholarly and practical resource for a broad audience of readers,” said Dr Zarbin, the Alfonse Cinotti MD/Lions Eye research professor and chair, Institute of Ophthalmology & Visual Science, Rutgers-New Jersey Medical School, Newark, NJ.
Referenced chapters
The book features 15 referenced chapters that are written by 44 contributors who represent leading experts in their fields. “Potential readers only need to read the preface of the book to determine whether or not it will be helpful to them,” Dr Zarbin said. “Then, with its list of contributors and the references at the end of each chapter, the book provides an excellent starting place for identifying personal contacts and material for further reading for anyone who wants to develop a more
mature understanding of a particular topic.”
Marco A Zarbin: zarbin@earthlink.net
Ricardo P Casaroli-Marano: rcasaroli@ub.edu
Latest Articles
Organising for Success
Professional and personal goals drive practice ownership and operational choices.
Update on Astigmatism Analysis
Is Frugal Innovation Possible in Ophthalmology?
Improving access through financially and environmentally sustainable innovation.
iNovation Innovators Den Boosts Eye Care Pioneers
New ideas and industry, colleague, and funding contacts among the benefits.
José Güell: Trends in Cornea Treatment
Endothelial damage, cellular treatments, human tissue, and infections are key concerns on the horizon.
Making IOLs a More Personal Choice
Surgeons may prefer some IOLs for their patients, but what about for themselves?
Need to Know: Higher-Order Aberrations and Polynomials
This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.
Never Go In Blind
Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.